insights_auto
Why is AIM down 3.36%?
Dive Deeperchevron_right
AIM:NYSEAMERICAN
AIM ImmunoTech Inc
$0.14
arrow_downward
-3.36%(-0.0050) 1D
$0.14
arrow_upward
+0.28% (+0.00040)todayPre-market
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AIM...
Open
$0.15
High
$0.15
Low
$0.14
Mkt. cap
5.68M
Avg. vol.
586.32K
Volume
27.06K
52-wk high
$1.88
52-wk low
$0.12
EPS
-$3.93
Beta
1.32
Shares outstanding
39.92M
No. of employees
20
Open
$0.15
High
$0.15
Low
$0.14
Mkt. cap
5.68M
Avg. vol.
586.32K
Volume
27.06K
52-wk high
$1.88
52-wk low
$0.12
EPS
-$3.93
Beta
1.32
Shares outstanding
39.92M
No. of employees
20
News stories
From web sources and news partners
Nieuws.nl
·
4 hours ago
AEX-index begint voorzichtig aan belangrijke week voor AI-sector
Nieuws.nl
·
3 days ago
AEX-index lager door onrust rond Nvidia
Opening Bell Daily
·
5 minutes ago
Berkshire stock: beat the S&P 500 in every dot-com bust year
TradingView
·
24 minutes ago
S&P 500, Nasdaq futures fall ahead of Nvidia earnings, Anthropic IPO
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees20
Founded1966
HeadquartersPhiladelphia, Pennsylvania, United States
SectorHealth Care
IndustryBiotechnology
Websiteaimimmuno.com